BP005722: Biotinylated Human TRAIL R1/DR4/TNFRSF10A Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human TRAIL R1/DR4/TNFRSF10A Protein, (amino acids Pro34-Asn239) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human TRAIL protein with the C-His-Avi tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Human TRAIL R1 protein with the C-His tag with the EC50 of 0.31 ug/ml determined by ELISA (QC Test). The affinity constant of 0.315 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005638: Biotinylated Human TRAIL R2/DR5/TNFRSF10B Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human TRAIL R2/DR5/TNFRSF10B Protein, (amino acids Ile56-Glu182) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human TRAIL R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Anti-TRAIL R2 Antibody protein with the C-hFc tag with the EC50 of 5.8 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005720: Biotinylated Human TRAIL R4/TNFRSF10D Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human TRAIL R4/TNFRSF10D Protein, (amino acids Ala56-His211) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human TRAIL protein with the C-His-Avi tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Human TRAIL R4 protein with the C-His tag with the EC50 of 0.14 ug/ml determined by ELISA (QC Test). The affinity constant of 0.135 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP000482-CG02: Recombinant Human Calcium-activated neutral proteinase 2 (CAPN2) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000482-PRO-330: Bovine Calcium-activated neutral proteinase 2 (CAPN2) Protein
Source: Bovine Myocardium-derived.
Purity: > 90% by SDS-PAGE.BP003625: Cynomolgus TRAIL R2/DR5/TNFRSF10B Protein with the C-His Tag
Source: The recombinant Cynomolgus TRAIL R2/DR5/TNFRSF10B Protein, (amino acids Ile58-Ser212) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Cynomolgus TRAIL R2 protein with the C-His tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-TRAIL R2 Antibody protein with the C-hFc tag with the EC50 of 3.9 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.C044P: Drozitumab Biosimilar, TRAIL Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade drozitumab biosimilar specifically binds to death receptor DR5 and induces apoptosis.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by drozitumab.BP002877-PRO-733: Recombinant Human Fas-Associated Death Domain (FADD) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP002541-ENZ-191: Recombinant Human GDP-Mannose 4,6-Dehydratase (GMDS) Enzyme
Source: E. coli-derived.
Purity: > 95% as determined by SDS-PAGE.BP002440-PRO-695: Recombinant Human Homer Homolog-1 (HOMER1) Protein
Source: E. coli-derived.
Purity: > 90% as determined by Analysis by SDS-PAGE.